This is an introductory course in economic evaluation in healthcare offered jointly by the School of Pharmacy’s Pharmaceutical Outcomes Research and Policy Program (https://sop.washington.edu/department-of-pharmacy/pharmaceutical-outcomes-research-policy-program-porpp/(link is external)) and the School of Public Health’s Institute for Public Health Genetics (http://depts.washington.edu/phgen/(link is external)). Attention is focused on cost-effectiveness and cost-benefit analysis, measures of health-related quality of life, technology assessment, resource allocation, pharmacoeconomics, and medical decision-making. We will also cover issues related to genomics, including cost-effectiveness of genetic testing and screening, and insurance and employment issues related to genetic information.
After this course, the student will be able to:
- Compare and contrast the different methods for economic evaluation in health care;
- Describe the instruments for measuring health state preferences;
- Evaluate a simple decision analysis model;
- Identify the role of economic evaluation in decision making and health policy;
- Critically evaluate a published cost-effectiveness study;
- Apply economic evaluation and health technology assessment to genetic tests